A
Reduction in best-corrected visual acuity
You're currently viewing VisionGenius-Ophthalmology as a guest. To save your results, create an account or log in.
Advertisement
With the FDA approval of plasminogen, human-tvmh (Ryplazim, Kedrion Biopharma) there is an effective treatment for plasminogen deficiency type 1 (PLGD-1), a rare systemic disorder characterized primarily by ligneous conjunctivitis. Here, test your knowledge of the PLGD-1 diagnosis.